SCHEMBL22200775

SCHEMBL22200775

CN(C)C1CCCC(NC(=O)OC(C)(C)C)C1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.66
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
GAA P10253 2/20 0.46
KMT2A Q03164 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
EPHX1 P07099 2/20 0.44
CTSK P43235 2/20 0.43
KDM1A O60341 1/20 0.41
MAOB P27338 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
HSD11B1 P28845 2/20 0.40
CYP2C9 P11712 1/20 0.40
EPHX2 P34913 1/20 0.38
DRD2 P14416 2/20 0.37
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24335931 0.92 BTK (0.55) BTKCA1CA2GAAKMT2A
SCHEMBL8328730 0.92 BTK (0.55) BTKCA1CA2GAAKMT2A
SCHEMBL8611872 0.92 BTK (0.55) BTKCA1CA2GAAKMT2A
SCHEMBL28735448 0.87 BTK (0.51) BTKCA1CA2GAAKMT2A
SCHEMBL28735308 0.87 BTK (0.51) BTKCA1CA2GAAKMT2A
SCHEMBL7205713 0.87 BTK (0.78) BTKCA1CA2GAAKMT2A
SCHEMBL14502820 0.87 BTK (0.78) BTKCA1CA2GAAKMT2A
SCHEMBL7212396 0.87 BTK (0.78) BTKCA1CA2GAAKMT2A
SCHEMBL7210932 0.87 BTK (0.78) BTKCA1CA2GAAKMT2A
SCHEMBL369297 0.83 BTK (0.72) BTKCA1CA2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142612-A1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH, INC. (US) 2020-07-09 WO disclosed